Ning Wei
- Cancer Research top 5%
- MicroRNA in disease regulation 5
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects 5
- Oncology top 5%
- Drug Transport and Resistance Mechanisms 4
- Colorectal Cancer Treatments and Studies 4
- Peptidase Inhibition and Analysis 4
- Molecular Biology top 10%
- Cancer therapeutics and mechanisms 5
- Cancer-related gene regulation 4
- Biophysics top 5%
-
- Selenium in Biological Systems 4
- Co-authors
- Sudhansu K. DeyRaymond N. DuBoisDingzhi WangHaibin WangEdward ChuKeith T. WilsonJoanne R. BrownRobert M. Strieter
- Cited by
- Cancer ResearchPharmacologyOncology
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Ning Wei
76 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 130
- Cancer Research 418
- Pharmacology 394
- Oncology 509
- Molecular Biology 1.1k
- Biophysics 86
Countries citing papers authored by Ning Wei
This map shows the geographic impact of Ning Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Wei more than expected).
Fields of papers citing papers by Ning Wei
This network shows the impact of papers produced by Ning Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Wei. The network helps show where Ning Wei may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ning Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 6 | |
| 4 | 2023 | 6 | |
| 5 | 2022 | 8 | |
| 6 | 2021 | 6 | |
| 7 | 2021 | 6 | |
| 8 | 2021 | 12 | |
| 9 | 2020 | 25 | |
| 10 | 2019 | 33 | |
| 11 | 2018 | 8 | |
| 12 | 2017 | 96 | |
| 13 | 2016 | 35 | |
| 14 | 2014 | 54 | |
| 15 | 2012 | 154 | |
| 16 | 2011 | 31 | |
| 17 | 2008 | 138 | |
| 18 | 2006 | 287 | |
| 19 | 2006 | 80 | |
| 20 | Oligo Saccharide Oligo-GlcNAc Induces Hypersensitive Cell Death and Enhances Disease Resistance in Rice | 2003 | 2 |
About Ning Wei
Ning Wei is a scholar working on Pharmacology, Cancer Research, Oncology, Toxicology and Molecular Biology, having authored 78 papers that have together received 2.4k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (5 papers), MicroRNA in disease regulation (5 papers), Cancer therapeutics and mechanisms (5 papers), Selenium in Biological Systems (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Colorectal Cancer Treatments and Studies (4 papers), Peptidase Inhibition and Analysis (4 papers) and Cancer-related gene regulation (4 papers). The work is most often cited by research in Cancer Research (418 citations), Pharmacology (394 citations), Oncology (509 citations), Molecular Biology (1.1k citations) and Biophysics (86 citations). Ning Wei has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Sudhansu K. Dey, Raymond N. DuBois, Dingzhi Wang, Haibin Wang, Edward Chu, Keith T. Wilson, Joanne R. Brown, Robert M. Strieter, John C. Schmitz and Takiko Daikoku. Their work appears in journals such as Cancer Research, Biochemical Pharmacology, PLoS ONE, Biomedicine & Pharmacotherapy and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.